Steve Perry
Impact in
- Biochemistry top 2%
- Eicosanoids and Hypertension Pharmacology
- Pharmacology top 10%
- Inflammatory mediators and NSAID effects
Papers in
- Biochemistry 11
- Eicosanoids and Hypertension Pharmacology 11
- Pharmacology 10
- Inflammatory mediators and NSAID effects 7
- Synthesis of Organic Compounds 2
- Co-authors
- Theodore R. Holman (15 shared papers)Netra Joshi (6 shared papers)Michael A. Holinstat (7 shared papers)Anton Simeonov (7 shared papers)Ajit Jadhav (7 shared papers)David J. Maloney (6 shared papers)Lena Schultz (5 shared papers)Domenico Praticò (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (3 papers)Biochemistry (3 papers)Journal of Lipid Research (1 paper)Archives of Biochemistry and Biophysics (1 paper)PLoS ONE (1 paper)
- Partner nations
- United StatesChileCanada
In The Last Decade
Steve Perry
18 papers receiving 798 citations
Peers
Comparison fields: 5 of 75
- Biochemistry 152
- Pharmacology 132
- Nutrition and Dietetics 108
- Pulmonary and Respiratory Medicine 162
- Neurology 72
Countries citing papers authored by Steve Perry
This map shows the geographic impact of Steve Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Perry more than expected).
Fields of papers citing papers by Steve Perry
This network shows the impact of papers produced by Steve Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Perry. The network helps show where Steve Perry may publish in the future.
Co-authors
The 25 scholars most cited alongside Steve Perry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 255 | |
| 2 | 2014 | 91 | |
| 3 | 2014 | 75 | |
| 4 | 2011 | 59 | |
| 5 | 2015 | 45 | |
| 6 | 2013 | 43 | |
| 7 | 2020 | 40 | |
| 8 | 2013 | 35 | |
| 9 | 2020 | 33 | |
| 10 | 2021 | 22 | |
| 11 | Discovery of ML355, a Potent and Selective Inhibitor of Human 12-Lipoxygenase | 2014 | 21 |
| 12 | 2013 | 19 | |
| 13 | 2020 | 17 | |
| 14 | Discovery of ML351, a Potent and Selective Inhibitor of Human 15-Lipoxygenase-1 | 2014 | 14 |
| 15 | 2013 | 12 | |
| 16 | 2014 | 10 | |
| 17 | 2023 | 10 | |
| 18 | 2022 | 5 |
About Steve Perry
Steve Perry is a scholar working on Biochemistry, Pharmacology, Nutrition and Dietetics, Organic Chemistry and Inorganic Chemistry, having authored 18 papers that have together received 806 indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (11 papers), Inflammatory mediators and NSAID effects (7 papers), Fatty Acid Research and Health (5 papers), Synthesis and biological activity (4 papers), Bioactive natural compounds (3 papers), Synthesis of Organic Compounds (2 papers), Metal-Catalyzed Oxygenation Mechanisms (2 papers) and Platelet Disorders and Treatments (1 paper). The work is most often cited by research in Biochemistry (152 citations), Pharmacology (132 citations), Nutrition and Dietetics (108 citations), Pulmonary and Respiratory Medicine (162 citations) and Neurology (72 citations). Steve Perry has collaborated with scholars based in United States, Chile and Canada. Frequent co-authors include Theodore R. Holman, Netra Joshi, Michael A. Holinstat, Anton Simeonov, Ajit Jadhav, David J. Maloney, Lena Schultz, Domenico Praticò, Cassandra M. Wilkinson and Yingxin Chen. Their work appears in journals such as Journal of Medicinal Chemistry, Biochemistry, Journal of Lipid Research, Archives of Biochemistry and Biophysics and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.